{
    "clinical_study": {
        "@rank": "67359", 
        "brief_summary": {
            "textblock": "RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells, and may be an\n      effective treatment for anaplastic oligodendroglioma. Combining combination chemotherapy\n      with radiation therapy may kill more tumor cells.\n\n      PURPOSE: Randomized phase III trial to compare radiation therapy with and without\n      combination chemotherapy in patients with resected anaplastic oligodendroglioma."
        }, 
        "brief_title": "Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma", 
        "condition": "Brain and Central Nervous System Tumors", 
        "condition_browse": {
            "mesh_term": [
                "Nervous System Neoplasms", 
                "Oligodendroglioma", 
                "Central Nervous System Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Compare survival and time to first progression in patients with anaplastic\n      oligodendroglioma treated with radiotherapy with or without adjuvant procarbazine,\n      lomustine, and vincristine (PCV) following surgical resection. II. Investigate the effect of\n      PCV on quality of life and neurologic function in these patients. III. Determine the\n      toxicity of PCV in these patients. IV. Correlate chromosomal lesions (1p and/or 19q, 9p, p53\n      loss and mutation, amplification of chromosome 7, or loss of chromosome 10) with\n      progression-free and overall survival in patients treated with these regimens.\n\n      OUTLINE: This is a randomized, multicenter study. Patients are stratified according to age,\n      extent of resection, performance status, prior surgery, and participating center. Patients\n      are randomized to one of two treatment arms. Arm I: Within 4-6 weeks after surgery, patients\n      undergo radiotherapy over 7 weeks to the residual tumor volume. Arm II: Patients undergo\n      radiotherapy as in arm I, then begin chemotherapy within 4 weeks after the completion of\n      radiotherapy. Patients receive oral lomustine on day 1, oral procarbazine on days 8-21, and\n      vincristine IV on days 8 and 29. Treatment repeats every 6 weeks in stable and responding\n      patients for a total of 6 courses. Patients with disease recurrence may receive 6 additional\n      courses of chemotherapy as above or another modality at the investigator's discretion.\n      Patients are followed every 3 months for 1 year and then every 6 months for survival.\n\n      PROJECTED ACCRUAL: A total of 350 patients will be accrued for this study within 4 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Newly diagnosed oligodendroglioma or oligoastrocytoma (with at\n        least 25% oligodendral elements) Low-grade oligodendroastrocytoma or oligodendroglioma\n        that is recurrent after surgery without radiotherapy is allowed Prior partial or gross\n        total resection of tumor (or biopsy only in case of no further surgical option) required\n        At least 3 of the following histologic anaplastic features: High cellularity Endothelial\n        abnormalities Nuclear abnormalities Necrosis Mitoses\n\n        PATIENT CHARACTERISTICS: Age: 16 to 69 Performance status: ECOG 0-2 Life expectancy: At\n        least 3 months Hematopoietic: WBC at least 3,000/mm3 Platelet count at least 100,000/mm3\n        Hepatic: Bilirubin no greater than 1.4 mg/dL Renal: Creatinine no greater than 1.3 mg/dL\n        Creatinine clearance at least 60 mL/min Other: Not pregnant or nursing Fertile patients\n        must use effective contraception No active or uncontrolled infection No other disease,\n        including malignancy, that would preclude study No neurologic or psychiatric disturbance\n        that would preclude study\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior\n        chemotherapy Endocrine therapy: Not specified Radiotherapy: See Disease Characteristics No\n        prior radiotherapy to the skull Surgery: See Disease Characteristics"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "69 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "350", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002840", 
            "org_study_id": "EORTC-26951", 
            "secondary_id": [
                "EORTC-26951", 
                "MRC-BR11"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "lomustine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "procarbazine hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "vincristine sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "radiation therapy", 
                "intervention_type": "Radiation"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Lomustine", 
                "Procarbazine", 
                "Vincristine"
            ]
        }, 
        "keyword": [
            "recurrent adult brain tumor", 
            "adult anaplastic oligodendroglioma", 
            "adult mixed glioma"
        ], 
        "lastchanged_date": "July 6, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-26951"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Vienna (Wien)", 
                        "country": "Austria", 
                        "zip": "A-1100"
                    }, 
                    "name": "Kaiser Franz Josef Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1070"
                    }, 
                    "name": "Hopital Universitaire Erasme"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels (Bruxelles)", 
                        "country": "Belgium", 
                        "zip": "1090"
                    }, 
                    "name": "Academisch Ziekenhuis der Vrije Universiteit Brussel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haine Saint Paul", 
                        "country": "Belgium", 
                        "zip": "7100"
                    }, 
                    "name": "Hopital de Jolimont"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "B-3000"
                    }, 
                    "name": "U.Z. Gasthuisberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Turku", 
                        "country": "Finland", 
                        "zip": "FIN-2-0521"
                    }, 
                    "name": "Turku University Central Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "Centre Hospitalier Regional de Lille"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13385"
                    }, 
                    "name": "CHU de la Timone"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nancy", 
                        "country": "France", 
                        "zip": "54035"
                    }, 
                    "name": "CHU de Nancy - Hopital Neurologique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes-Saint Herblain", 
                        "country": "France", 
                        "zip": "44805"
                    }, 
                    "name": "CRLCC Nantes - Atlantique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06189"
                    }, 
                    "name": "Centre Antoine Lacassagne"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06002"
                    }, 
                    "name": "Hopital Pasteur"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nimes", 
                        "country": "France", 
                        "zip": "30000"
                    }, 
                    "name": "C.H.R. de Nimes - Hopital Caremeau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75651"
                    }, 
                    "name": "CHU Pitie-Salpetriere"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "zip": "35064"
                    }, 
                    "name": "Centre Eugene Marquis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "F-94805"
                    }, 
                    "name": "Institut Gustave Roussy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "D-30559"
                    }, 
                    "name": "Neurologische Klinik der Henriettenstiftung"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jena", 
                        "country": "Germany", 
                        "zip": "D-07740"
                    }, 
                    "name": "Klinikum der Friedrich-Schiller Universitaet Jena"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "1145"
                    }, 
                    "name": "National Institute of Neurosurgery"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Padova", 
                        "country": "Italy", 
                        "zip": "35128"
                    }, 
                    "name": "Universita di Padova"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Padova (Padua)", 
                        "country": "Italy", 
                        "zip": "35128"
                    }, 
                    "name": "Azienda Ospedaliera di Padova"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "'s-Gravenhage (Den Haag, The Hague)", 
                        "country": "Netherlands", 
                        "zip": "2501 CK"
                    }, 
                    "name": "Medisch Centrum Haaglanden"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1105 AZ"
                    }, 
                    "name": "Academisch Medisch Centrum"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1001HV"
                    }, 
                    "name": "Vrije Universiteit Medisch Centrum"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Groningen", 
                        "country": "Netherlands", 
                        "zip": "9713 EZ"
                    }, 
                    "name": "Academisch Ziekenhuis Groningen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "NL-6500 HB"
                    }, 
                    "name": "University Medical Center Nijmegen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3075 EA"
                    }, 
                    "name": "Rotterdam Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tilburg", 
                        "country": "Netherlands", 
                        "zip": "5022 GC"
                    }, 
                    "name": "St. Elisabeth Ziekenhuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tilburg", 
                        "country": "Netherlands", 
                        "zip": "5042 SB"
                    }, 
                    "name": "Dr. Bernard Verbeeten Instituut"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3584 CX"
                    }, 
                    "name": "Academisch Ziekenhuis Utrecht"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lisbon", 
                        "country": "Portugal", 
                        "zip": "1093"
                    }, 
                    "name": "Instituto Portugues de Oncologia de Francisco Gentil"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Linkoping", 
                        "country": "Sweden", 
                        "zip": "S-581 85"
                    }, 
                    "name": "University Hospital of Linkoping"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Umea", 
                        "country": "Sweden", 
                        "zip": "S-901 85"
                    }, 
                    "name": "Umea Universitet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland", 
                        "zip": "CH-1011"
                    }, 
                    "name": "Centre Hospitalier Universitaire Vaudois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nottingham", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "NG5 1PB"
                    }, 
                    "name": "Nottingham City Hospital NHS Trust"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nottingham", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "NG1 6HA"
                    }, 
                    "name": "Nottingham General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nottingham", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "NG7 2UH"
                    }, 
                    "name": "Queen's Medical Centre"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Southampton", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "SO14 0YG"
                    }, 
                    "name": "Royal South Hants Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Southampton", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "SO16 6YD"
                    }, 
                    "name": "Southampton General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sutton", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "SM2 5PT"
                    }, 
                    "name": "Royal Marsden Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "Belgium", 
                "Finland", 
                "France", 
                "Germany", 
                "Hungary", 
                "Italy", 
                "Netherlands", 
                "Portugal", 
                "Sweden", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "official_title": "PHASE III STUDY OF ADJUVANT PROCARBAZINE, CCNU AND VINCRISTINE CHEMOTHERAPY IN PATIENTS WITH HIGHLY ANAPLASTIC OLIGODENDROGLIOMA", 
        "overall_official": {
            "affiliation": "Daniel Den Hoed Cancer Center at Erasmus Medical Center", 
            "last_name": "Martin J. van Den Bent, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2002", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002840"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "20820870", 
                "citation": "Idbaih A, Dalmasso C, Kouwenhoven M, Jeuken J, Carpentier C, Gorlia T, Kros JM, French P, Teepen J, Bro\u00ebt P, Delattre O, Mokhtari K, Sanson M, Delattre JY, van den Bent M, Hoang-Xuan K. Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951. J Neurooncol. 2010 Sep 6; [Epub ahead of print]"
            }, 
            {
                "PMID": "21246521", 
                "citation": "Mokhtari K, Ducray F, Kros JM, Gorlia T, Idbaih A, Taphoorn M, Wesseling P, Hoang-Xuan K, Van den Bent M, Sanson M. Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951. Cancer. 2011 Jul 1;117(13):3014-26. doi: 10.1002/cncr.25827. Epub 2011 Jan 18."
            }, 
            {
                "PMID": "21914791", 
                "citation": "van den Bent MJ, Gravendeel LA, Gorlia T, Kros JM, Lapre L, Wesseling P, Teepen JL, Idbaih A, Sanson M, Smitt PA, French PJ. A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951. Clin Cancer Res. 2011 Nov 15;17(22):7148-55. doi: 10.1158/1078-0432.CCR-11-1274. Epub 2011 Sep 13."
            }, 
            {
                "citation": "Preusser M, Hoeftberger R, Woehrer A, et al.: Prognostic value and analytical performance (reproducibility) of Ki67 index in anaplastic oligodendroglial tumors: A translational study of the EORTC Brain Tumor Group. [Abstract] J Clin Oncol 28 (Suppl 15): A-2029, 2010."
            }, 
            {
                "PMID": "20160062", 
                "citation": "van den Bent MJ, Dubbink HJ, Marie Y, Brandes AA, Taphoorn MJ, Wesseling P, Frenay M, Tijssen CC, Lacombe D, Idbaih A, van Marion R, Kros JM, Dinjens WN, Gorlia T, Sanson M. IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Clin Cancer Res. 2010 Mar 1;16(5):1597-604. doi: 10.1158/1078-0432.CCR-09-2902. Epub 2010 Feb 16."
            }, 
            {
                "PMID": "19224764", 
                "citation": "Kouwenhoven MC, Gorlia T, Kros JM, Ibdaih A, Brandes AA, Bromberg JE, Mokhtari K, van Duinen SG, Teepen JL, Wesseling P, Vandenbos F, Grisold W, Sipos L, Mirimanoff R, Vecht CJ, Allgeier A, Lacombe D, van den Bent MJ. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951. Neuro Oncol. 2009 Feb 17; [Epub ahead of print]"
            }, 
            {
                "PMID": "19901104", 
                "citation": "van den Bent MJ, Dubbink HJ, Sanson M, van der Lee-Haarloo CR, Hegi M, Jeuken JW, Ibdaih A, Brandes AA, Taphoorn MJ, Frenay M, Lacombe D, Gorlia T, Dinjens WN, Kros JM. MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951. J Clin Oncol. 2009 Nov 9; [Epub ahead of print]"
            }, 
            {
                "PMID": "17549014", 
                "citation": "Kros JM, Gorlia T, Kouwenhoven MC, Zheng PP, Collins VP, Figarella-Branger D, Giangaspero F, Giannini C, Mokhtari K, Mork SJ, Paetau A, Reifenberger G, van den Bent MJ. Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome. J Neuropathol Exp Neurol. 2007 Jun;66(6):545-51."
            }, 
            {
                "PMID": "18089867", 
                "citation": "Mauer ME, Taphoorn MJ, Bottomley A, Coens C, Efficace F, Sanson M, Brandes AA, van der Rijt CC, Bernsen HJ, Fr\u00e9nay M, Tijssen CC, Lacombe D, van den Bent MJ; EORTC Brain Cancer Group. Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol. 2007 Dec 20;25(36):5731-7."
            }, 
            {
                "PMID": "18089866", 
                "citation": "Taphoorn MJ, van den Bent MJ, Mauer ME, Coens C, Delattre JY, Brandes AA, Sillevis Smitt PA, Bernsen HJ, Fr\u00e9nay M, Tijssen CC, Lacombe D, Allgeier A, Bottomley A; European Organisation for Research and Treatment of Cancer. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol. 2007 Dec 20;25(36):5723-30."
            }, 
            {
                "PMID": "16782911", 
                "citation": "van den Bent MJ, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJ, Bernsen HJ, Frenay M, Tijssen CC, Grisold W, Sipos L, Haaxma-Reiche H, Kros JM, van Kouwenhoven MC, Vecht CJ, Allgeier A, Lacombe D, Gorlia T. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol. 2006 Jun 20;24(18):2715-22."
            }, 
            {
                "citation": "van den Bent MJ, Delattre JY, Brandes AA, et al.: First analysis of EORTC trial 26951, a randomized phase III study of adjuvant PCV chemotherapy in patients with highly anaplastic oligodendroglioma. [Abstract] J Clin Oncol 23 (Suppl 16): A-1503, 114s, 2005."
            }
        ], 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "collaborator": {
                "agency": "Medical Research Council", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 1996", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }, 
    "geocoordinates": {
        "Academisch Medisch Centrum": "52.37 4.895", 
        "Academisch Ziekenhuis Groningen": "53.219 6.567", 
        "Academisch Ziekenhuis Utrecht": "52.09 5.11", 
        "Academisch Ziekenhuis der Vrije Universiteit Brussel": "50.85 4.352", 
        "Azienda Ospedaliera di Padova": "45.41 11.877", 
        "C.H.R. de Nimes - Hopital Caremeau": "43.837 4.36", 
        "CHU Pitie-Salpetriere": "48.857 2.352", 
        "CHU de Nancy - Hopital Neurologique": "48.692 6.184", 
        "CHU de la Timone": "43.296 5.37", 
        "CRLCC Nantes - Atlantique": "47.21 -1.602", 
        "Centre Antoine Lacassagne": "43.696 7.266", 
        "Centre Eugene Marquis": "48.113 -1.676", 
        "Centre Hospitalier Regional de Lille": "50.629 3.057", 
        "Centre Hospitalier Universitaire Vaudois": "46.52 6.634", 
        "Dr. Bernard Verbeeten Instituut": "51.586 5.079", 
        "Hopital Pasteur": "43.696 7.266", 
        "Hopital Universitaire Erasme": "50.85 4.352", 
        "Hopital de Jolimont": "50.453 4.191", 
        "Institut Gustave Roussy": "48.793 2.359", 
        "Instituto Portugues de Oncologia de Francisco Gentil": "38.707 -9.136", 
        "Kaiser Franz Josef Hospital": "48.208 16.374", 
        "Klinikum der Friedrich-Schiller Universitaet Jena": "50.927 11.589", 
        "Medisch Centrum Haaglanden": "52.077 4.316", 
        "National Institute of Neurosurgery": "47.498 19.041", 
        "Neurologische Klinik der Henriettenstiftung": "52.384 9.727", 
        "Nottingham City Hospital NHS Trust": "52.955 -1.158", 
        "Nottingham General Hospital": "52.955 -1.158", 
        "Queen's Medical Centre": "52.955 -1.158", 
        "Rotterdam Cancer Institute": "51.924 4.482", 
        "Royal Marsden Hospital": "51.361 -0.194", 
        "Royal South Hants Hospital": "50.91 -1.404", 
        "Southampton General Hospital": "50.91 -1.404", 
        "St. Elisabeth Ziekenhuis": "51.586 5.079", 
        "Turku University Central Hospital": "60.449 22.259", 
        "U.Z. Gasthuisberg": "50.878 4.704", 
        "Umea Universitet": "63.826 20.263", 
        "Universita di Padova": "45.41 11.877", 
        "University Hospital of Linkoping": "58.411 15.621", 
        "University Medical Center Nijmegen": "51.843 5.855", 
        "Vrije Universiteit Medisch Centrum": "52.37 4.895"
    }
}